Cactus Compositum Dps 3 D / 100 mL Drops is a Health Canada–registered human drug (DIN 02026368) held by Biologische Heilmittel Heel GmbH, containing Spigelia. Health Canada lists its status as Cancelled Post Market (status date 12 Jul 2001). Nexara Health has matched 1 registration of Spigelia across 1 other regulated market.
Health Canada registration
| DIN | 02026368 |
|---|---|
| Brand name | Cactus Compositum Dps |
| Active ingredient | Spigelia |
| Strength | 3 D / 100 mL |
| Dosage form | Drops |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 12 Jul 2001 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Spigelia registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | BM Spigelia | BM Private Limited | Globule | listed | FDA NDC |
See every manufacturer of Spigelia worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cactus Compositum Dps (DIN 02026368) marketed in Canada?
No. Health Canada lists DIN 02026368 as Cancelled Post Market as of 12 Jul 2001.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Spigelia registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02026368, status date 2001-07-12; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02026368, status date 2001-07-12; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02026368, status date 2001-07-12; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.